Our commitment to you and your patients
Hologic is dedicated to helping you protect women with the most effective cervical cancer screening methods available. As part of this commitment, we recognize the importance of the Pap test in the fight against cervical cancer. After the widespread adoption of the Pap test in the 1950s, death rates associated with cervical cancer decreased by almost 70%.1 To this day, it remains the single most effective screening test for preventing any kind of cancer.
The ThinPrep® Pap test
In 1996 Hologic introduced liquid-based cytology (LBC) with the ThinPrep Pap test, which has become the most widely used Pap test in the US. The Pap test has greatly reduced the incidence of cervical cancer by detecting abnormal cells on the cervix, often before they develop into precancerous cells or cervical cancer.2 Today, what was once the leading cause of cancer death for women in the US ranks 14th in frequency.1